CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tego Science Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tego Science Inc
93, Magokjungang 8-ro, Gangseo-gu
Phone: +82 28182900p:+82 28182900 SEOUL, 07794  South Korea Ticker: 191420191420
Business Summary
Tego Science Inc is a Korea-based company principally engaged in the manufacture and distribution of biopharmaceuticals. The Company is principally engaged in the research, development, manufacture and distribution of cell therapy products used for the treatment of third-degree and severe burns, deep second-degree burns, diabetic foot ulcers and under-eye wrinkles. The Company is engaged in the manufacture and sale of artificial skins used for testing the efficacy and safety of pharmaceuticals and cosmetics as well as for screening new drugs. In addition, the Company is engaged in the provision of biopharmaceutical contract manufacturing and development organization (CDMO) services and experimental services. The Company is also engaged in the property rental.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
3842 Orthopedic, prosthetic, and surgical appliances and supplies
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director Se HwaJeon 47
Internal Auditor Byeong HaeNoh 76
Director Jae WukJeon 50
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 40 (As of 6/30/2022)
Outstanding Shares: 8,006,566 (As of 9/30/2025)
Shareholders: 6,211
Stock Exchange: KDQ
Fax Number: +82 221073173


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 6, 2025